Search results
Author(s):
Alexandre Mebazaa
,
Harriette Van Spall
Added:
1 year ago
AHA 22 - Late-breaker host Dr Harriette Van Spall (McMaster University, CA) is joined by Prof Alexandre Mebazaa (University Hospitals Saint Louis‐Lariboisière, FR), the primary investigator of the anticipated STRONG-HF Trial (NCT03412201).
This study aimed to evaluate the safety and efficacy of rapid-optimization heart failuretherapies. 1800 patients were randomized to receive either usual care…
View more
Author(s):
Moritake Iguchi
,
Hiromichi Wada
,
Felipe Martínez
,
et al
Added:
9 months ago
Author(s):
Ovidiu Chioncel
Added:
4 years ago
Prof Ovidiu Chioncel (University of Medicine Carol Davilla, Bucuresti, RO) discusses insights from theESC EORP HFA Heart Failure Long Term Registry –Acute heart failure congestion and perfusion status; impact of the clinical classification on in hospital and long-term outcomes.
Filmed on site at HFA 2019 by Radcliffe Cardiology.
Videographer: Mike Knight
Interviewer: Liam O'Neill
View more
L Christian Napp
Job title: MD Hannover Medical School, Hannover, Germany
Author
Sean Lal
Job title: Associate Professor
Author
Paolo Canova
Author
Piotr Ponikowski
Research Area(s) / Expertise:
Job title: Head of the Department of Heart Diseases
Author
Fabio Guarracino
Job title: Head of the Department of Anesthesia and Critical Care Medicine
Author
Author(s):
Bao Tran
,
Gregg C Fonarow
Added:
3 years ago
Heart failure (HF) remains a major public health problem resulting in substantial morbidity, mortality and healthcare expenditures globally. The European Society of Cardiology (ESC) 2012 Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure and the American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) 2013 Guideline for the Management of Heart…
View more
Added:
1 year ago
HFSA 22 - In this interview, Dr Juuso Blomster (Precordior Ltd, Turku, FI) joins us to share the results of the REFLECS Trial (NCT04378179), originally presented at HFSA 2022.
This trial aimed to evaluate the Precordior CardioSignal app's efficacy in measuring patients cardiac motion and function in comparison to echocardiography. Over 200 patients were recruited to this observational study.
…
View more